ARS Pharmaceuticals earnings
When SPRY reports, and what its stock did after each report.
Next report
Expected around early February, going by its own filing history. The company has not announced a date yet. Its matching report came Jan 13, 2025, after the close.
Who else reports that week: the earnings calendar.
Last report: Nov 5, 2026, 16:04 ET (after the close). The filing on SEC EDGAR ↗
After each report
SEC EDGAR · 1D EODAcross the last 5 reports we hold closes for, the first close moved a median 5.28% either way. Up 2 of 5.
Moves are only shown for reports where we hold closing prices.
- Nov 5, 202616:04 ET · after the close8-K ↗+5.28%1DRevenue $37.71M+16.0% y/yEPS −$0.36quarter to Sep 30, 2026
- Aug 13, 202616:03 ET · after the close8-K ↗−7.38%1DRevenue $33.66M+114.2% y/yEPS −$0.63quarter to Jun 30, 2026
- May 15, 202606:02 ET · before the open8-K ↗−6.49%1DRevenue $22.68M+184.5% y/yEPS −$0.61quarter to Mar 31, 2026
- Mar 9, 202606:01 ET · before the open8-K ↗−0.11%1DRevenue $28.09M−67.6% y/yquarter to Dec 31, 2025
- Nov 10, 202506:02 ET · before the open8-K ↗+0.34%1DRevenue $32.50M+1471.6% y/yEPS −$0.52quarter to Sep 30, 2025
- Before Sep 2, 2025 we don't hold closing prices, so these reports show the date and what was filed, without a move.
- Aug 13, 202507:02 ET · before the open8-K ↗Revenue $15.72M+3043.4% y/yEPS −$0.46quarter to Jun 30, 2025
- May 14, 202507:01 ET · before the open8-K ↗Revenue $7.97MEPS −$0.35quarter to Mar 31, 2025
- Mar 20, 202507:02 ET · before the open8-K ↗Revenue $86.58Mquarter to Dec 31, 2024
- Jan 13, 202508:08 ET · before the open8-K ↗Revenue $86.58Mquarter to Dec 31, 2024
- Nov 13, 202407:00 ET · before the open8-K ↗Revenue $2.07MEPS −$0.20quarter to Sep 30, 2024
- Aug 6, 202416:04 ET · after the close8-K ↗Revenue $500.0K+4900.0% y/yEPS −$0.13quarter to Jun 30, 2024
- May 9, 202416:08 ET · after the close8-K ↗Revenue $0.00K−100.0% y/yEPS −$0.11quarter to Mar 31, 2024
- Mar 21, 202416:06 ET · after the close8-K ↗Revenue $0.00Kquarter to Dec 31, 2023
- Nov 9, 202316:02 ET · after the close8-K ↗Revenue $0.00K−100.0% y/yEPS −$0.16quarter to Sep 30, 2023
- Aug 10, 202316:05 ET · after the close8-K ↗Revenue $10.00K−97.8% y/yEPS −$0.18quarter to Jun 30, 2023
Move = the first close after the release against the close before it. A release after 4pm ET is priced by the next session; one before 9:30am ET by that day’s. Times are when the SEC accepted the 8-K (Item 2.02), which follows the press release by minutes. Closes held from Sep 2, 2025; “no price data” means we don't hold the closes for that report. 1 other Item 2.02 filing, filed weeks ahead of a report (a delivery or preliminary update), is not counted as a report. Prior-session closes only; not a forecast, not advice.